Stories are generated from ORTEX data and reviewed by the ORTEX team. How we publish
Tyler Technologies heads into its October 28 earnings report with the Street turning more cautious and the stock still 9% below where it traded a month ago.
The most significant development this week is a Goldman Sachs downgrade filed this morning. Adam Hotchkiss cut TYL from Buy to Neutral and trimmed his target from $395 to $345, just $13 above the current $332.34 price. That move is hard to ignore: Goldman stepping off a Buy rating three weeks before a print signals that the risk/reward has narrowed materially. The broader analyst picture is one of steady target compression. Piper Sandler maintained Overweight last week but cut its target to $450 from $491. BTIG held Buy at $400. JP Morgan, which had a $650 target as recently as June, lowered to $525 around that time. The mean target now sits at $424.77, implying about 28% upside from current levels, but the direction of revisions has been consistently downward since mid-year.
The bull and bear cases are clearly drawn. Bulls point to Tyler's dominant position in government software, where high switching costs and property-tax-backed local budgets provide durable revenue. Management has guided for 21.5% to 23.5% SaaS growth in 2026, and free cash flow has roughly doubled since 2021 to $621 million. The ORTEX factor score for 12-month forward EPS growth ranks in the 87th percentile, the strongest factor on the sheet. Bears counter that 70% to 75% of revenue depends on local government budgets that are tightening as pandemic relief funds expire. Maintenance and support revenue fell from $474 million in 2021 to $446 million in 2025, legacy software licenses have nearly vanished, and AI-driven competition is an emerging threat. The EV/EBITDA multiple has barely moved off 16x despite the price decline, leaving valuation stretched relative to fundamentals.
Positioning in the lending market gives short sellers no particular edge. Availability is running at 505%, meaning there are five shares available to borrow for every one already short, well above the 52-week tightest reading of 165%. Cost to borrow is 0.60%, essentially free. Short interest is 7.2% of the free float, a meaningful level but down 11% over the past month as some bears covered into the September weakness. The short score of 51.6 is mid-range and has been flat for two weeks, suggesting neither accumulation nor a washout. Options traders have edged slightly more defensive, with the put/call ratio at 0.46, about 1.25 standard deviations above the 20-day average of 0.42, but still far from the 52-week high of 0.87. The setup looks cautious rather than crowded.
The earnings history deserves attention ahead of the October 28 release. The last three quarterly prints all produced negative first-day reactions: the July 2026 result sent the stock down 7.2% on the day and 8.1% over the following week. The prior quarter also saw a 3.9% one-day drop. That pattern of selling on results, even with intact long-term growth, explains some of the caution in both analyst targets and options pricing. Institutional holders are largely passive and steady: BlackRock holds 9.4% and added modestly, State Street added 105,000 shares, and Norges Bank built a new position of 701,000 shares over the June quarter. No activist has filed a 13D, and the 13G register shows no contested intent.
On the insider front, the meaningful recent activity has been sales. CEO H. Lynn Moore sold 9,250 shares at $372.79 in late August for roughly $3.4 million, an exercise-and-sell pairing, not a discretionary open-market purchase. COO Jeffrey Puckett executed a similar transaction, selling 8,500 shares at $356.44 for $3 million. Neither trade carries the signal weight of a discretionary open-market purchase, but the pattern of net selling at prices well above current levels adds context to the September decline.
The October 28 print is where this note resolves: the question is whether SaaS growth has accelerated enough to offset the compression in legacy revenue lines, and whether management updates full-year guidance in a way that justifies any multiple beyond 16x EBITDA.
See the live data behind this article on ORTEX.
Open TYL on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.
